Hong Kong · Industrial & Consumer Products · HKD (Thousands) · Annual
Reported figures and Equlion model projections for the next 4 years.
Amounts in HKD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for CHI LONGEVITY? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | |||
|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | 7.41% | 6.97% | 3.84% | 3.67% | 3.49% |
|---|---|---|---|---|---|
| ROA | 2.86% | 2.71% | 1.52% | 1.48% | 1.44% |
| Gross Margin | 17.4% | 16.91% | 15% | 15% | 15% |
| Net Margin | 4.77% | 4.38% | 2.58% | 2.57% | 2.55% |
| Total Assets | HK$1,940,474.00K | HK$2,055,516.66K | HK$2,091,814.19K | HK$2,120,133.91K | HK$2,147,209.19K |
| Net Income | HK$55,552.00K | HK$54,144.11K | HK$31,452.75K | HK$31,219.89K | HK$30,787.63K |